LighthouseAI Raises $8 Million Series A

Round led by Boxcars Ventures will support expanded product development, including the launch of Rapid Assessments

LighthouseAI, the central intelligence and management platform for pharmaceutical state licensing and compliance, today announced the close of an $8 million Series A financing round. The round was led by Boxcars Ventures, with participation from TGVP and existing investors.

The company has doubled its customer base since January 2025 and now serves 250 customers across the pharmaceutical supply chain, including manufacturers, wholesale distributors, third-party logistics providers, 503B outsourcing facilities, pharmacies, and repackagers. More than 15 software customers are pharmaceutical enterprises with over $1 billion in annual revenue. In 2025, LighthouseAI processed change-of-ownership transactions for companies representing more than $12 billion in combined revenue.

The company initially achieved profitability in Q4 2025. Series A proceeds will be directed primarily toward delivery improvements, product development, and service expansion in support of the expected growth trajectory.

Rapid Assessments

As part of its product roadmap, LighthouseAI launched Rapid Assessments. The product analyzes more than 100 attributes of a given facility, utilizing deterministic technology, and produces a guaranteed set of regulatory requirements across 55 U.S. jurisdictions instantly.

Historically, this process required weeks of manual statutory research performed by a team of lawyers or consultants.

Team

LighthouseAI employs 85 people, roughly double its headcount from two years ago. The company recently appointed Bill Versosky as Chief Commercial Officer to fuel the next phase of growth.

"We are proud of what our team has built and the trust our customers have placed in us," said Sumeet Singh, Founder and CEO of LighthouseAI. "This funding allows us to continue the growth we've worked for. We are grateful for the dedication of our employees and the loyalty of our customers."

About LighthouseAI

LighthouseAI is the central system for pharmaceutical licensing and compliance. Combining software and technology with a robust team of state licensing experts who provide professional services, LighthouseAI centralizes licensing across every U.S. state and jurisdiction for manufacturers, wholesale distributors, 3PLs, 503A and 503B facilities, pharmacies, repackagers, reverse distributors, virtual manufacturers, and healthcare providers. Learn more at LighthouseAI.com.

###

Media Contact

Ryan Hall
Director of Marketing
[email protected]

SOURCE: LighthouseAI

Source: LighthouseAI

Share:


Tags: Compliance, LighthouseAI, Regulation, Series A, Software


About LighthouseAI

View Website or Media Room

NCDQS evaluates entities in the pharmaceutical and cannabis supply chain for compliance with Federal and State regulations and industry best practices.

LighthouseAI
1325 Palmetto Street
Los Angeles, CA 90013
United States